相关实验视频
Updated: Jun 26, 2025

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.3K
结合循环与 thiazide 利尿剂在心力衰竭不补偿后出院的患者:与30天结果的关联
Òscar Miró1, Julio Núñez2, Joan Carles Trullàs3
1Emergency Department, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Catalonia, Spain; The GREAT network, Rome, Italy.
European journal of internal medicine
|May 19, 2024
概括
将 thiazide 利尿剂添加到循环利尿剂并没有显著改变急性心力衰竭住院患者的短期结果. 这种组合在出院后30天内没有增加死亡或住院的风险.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 急性心力衰竭 (AHF) 是住院的主要原因.
- 优化出院药物治疗对于改善患者治疗结果至关重要.
- 循环利尿剂是标准疗法,但补充类亚酸的作用不太清楚.
研究的目的:
- 评估添加 thiazide 利尿剂添加到循环利尿剂对 AHF 幸存者的短期结果的影响.
- 分析与30天死亡率,住院和复合事件的关联.
主要方法:
- 从三个独立的队列中对14,403名患者进行了二次分析.
- 患者根据出院药物分层:单独循环利尿剂与循环和 thiazide 利尿剂.
- 对患者和药物变量进行调整的考克斯回归分析被用于评估结果.
主要成果:
- 9.5%的患者在出院时接受了循环和 thiazide 利尿剂.
- 组合疗法对所有分析结果都表现为中性.
- 调整后的危险比率表明30天死亡,住院或综合事件没有显著变化.
结论:
- 在AHF幸存者中,将 thiazide 和循环利尿剂结合使用与短期结果的不良或有益变化无关.
- 目前的证据表明它具有中性效应,因此需要对特定患者亚组进行进一步调查.
更多相关视频
相关概念视频
Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
Antihypertensive Drugs: Thiazide-Class Diuretics
604
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
604
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Antihypertensive Drugs: Potassium-Sparing Diuretics
521
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
521
Antihypertensive Drugs: Action of Diuretics
670
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
670
Discharge Summary Forms
751
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
751

